Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada

BACKGROUND: Ticagrelor demonstrated a significant reduction in major cardiac events in patients with acute coronary syndrome (ACS) compared with clopidogrel in the Platelet Inhibition and Patient Outcomes (PLATO) trial. The objective of this study was to assess the cost-effectiveness of ticagrelor c...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Grima, Daniel T, Brown, Stephen T, Kamboj, Laveena, Bainey, Kevin R, Goeree, Ron, Oh, Paul, Ramanathan, Krishnan, Goodman, Shaun G
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2014
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3908913/
https://ncbi.nlm.nih.gov/pubmed/24493930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S51052
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky